Brief: Guard Therapeutics Q2 Loss After Tax At SEK 21 Million
Aug 23 (Reuters) - Guard Therapeutics International AB
(publ) GUARD.ST :
* Q2 NET SALES SEK 0
* Q2 LOSS BEFORE AND AFTER TAX AT SEK 21 MILLION VERSUS LOSS
11.6
MILLION YEAR AGO
Source text for Eikon: ID:nMFN8mZ1x7
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover